This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against COVID-19, in Cambridge, Mass., on May 18, 2020. Brian Snyder/Reuters
The announcement by Moderna of a vaccine against COVID-19 that is “95 per cent effective” understandably raises spirits (and the stock market) for a second time, more even than did the announcement by Pfizer of the previous successful vaccine.
Theodore Dalrymple is a retired doctor. He is contributing editor of the City Journal of New York and the author of 30 books, including “Life at the Bottom.” His latest book is “Embargo and Other Stories.”
